Live feed17:57:43·504dINSIDERFilingvia QuantisnowSVP, Chief Scientific Officer Belvin Marcia was granted 87,500 shares, increasing direct ownership by 50% to 263,148 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CTMX· CytomX Therapeutics Inc.Health CareOriginal source
